Lydall Awarded $13.5M Contract by U.S. Department of Defense to Support American-Made Face Mask Production

Rhea-AI Summary

Lydall has announced a $13.5 million contract with the U.S. Department of Defense to fund the installation of two new meltblown production lines in Rochester, New Hampshire. This investment aims to increase domestic production of filtration media vital for N95 respirators and surgical masks. By May 2021, Lydall will support the production of 140 million N95 respirators and 540 million surgical masks monthly. This will make Lydall the largest U.S. site for meltblown filtration media, enhancing its ability to address both COVID-19 and future air quality concerns.

Positive

• Contract award of $13.5 million with the U.S. Department of Defense.
• Increased capacity for 140 million N95 respirators and 540 million surgical masks monthly by May 2021.
• Establishment of the largest meltblown filtration media production site in the U.S.
• Support for domestic supply chains and job creation.

Negative

• None.

• Lydall Invests in Second New Fine Fiber Meltblown Production Line to Supply Face Mask Filtration Media to Combat COVID-19
• Company to Provide the Critical Filtration Component for 1.7B N95 Respirators or 6.5B Surgical Masks Per Year
• New Capacity Makes Lydall the Largest Meltblown Filtration Media Site in United States

MANCHESTER, Conn., June 30, 2020 (GLOBE NEWSWIRE) -- Lydall, Inc. (NYSE: LDL), a leading U.S. manufacturer of value-added engineered materials and specialty filtration solutions that create a cleaner, safer and quieter world, today announced the signing of a $13.5 million contract award with the United States Department of Defense (DOD). The contract will support Lydall’s investment in two new meltblown production lines – including one that had been announced on June 2 – in its Rochester, New Hampshire facility. This investment will significantly accelerate Lydall’s domestic production of meltblown filtration media that comprises the critical filtration layer of N95 respirators and surgical masks. By May 2021, Lydall will increase its capacity of meltblown filtration media to support the monthly domestic production of 140 million N95 respirators or 540 million surgical masks, and of high-performing air filtration media to improve air quality in indoor spaces.

“Face masks are the ‘armor’ that protects Americans from contracting COVID-19. As with the equipment the U.S. military provides our soldiers, our face masks, and the filtration media inside, must be highly engineered, backed by science and adhere to the rigorous standards of the National Institute for Occupational Safety and Health (NIOSH), a division of the CDC,” said Sara A. Greenstein, President & CEO of Lydall. “We are incredibly thankful to the U.S. government for recognizing the importance of accelerating domestic production of N95 and surgical face masks and providing the grant we need to do just that. We also want to congratulate the state of New Hampshire and the city of Rochester on this investment and are grateful for their collaboration and partnership. Together, we are supporting domestic supply chains, creating American jobs and contributing to the fight against COVID-19.”

With the installation of these two new production lines, Lydall’s New Hampshire facility will be the largest site for meltblown filtration media production in the United States and a center of excellence for advanced filtration media innovation. To support the wider need for improved air quality beyond COVID-19, Lydall’s innovation team is focused on developing new carbon-based, high-efficiency media for MERV-, HEPA- and ULPA-grade filters for hospitals, airplanes, restaurants, office buildings and other public spaces. Lydall expects to generate new jobs to support the increase in production.

“As a market leader in specialty filtration solutions for nearly 100 years, we are proud to bring the full extent of our deep manufacturing expertise, assets and people to bear in the production of personal protective equipment for our first responders, medical professionals, military personnel and the general public,” Ms. Greenstein added. “We have done everything within our capacity to ramp up our production of filtration media for N95 respirators and surgical face masks. With the support of the U.S. government, we will increase production even further.”

This contract award is a product of the ongoing collaboration between the Department of Defense and the Department of Health and Human Services, led by the Department’s Joint Acquisition Task Force and funded through the Coronavirus Aid, Relief, and Economic Security (CARES) Act.

For more information on Lydall’s COVID-19-related products, visit https://lydall.com/covid-19-relief-effort.

About Lydall, Inc.
Headquartered in Manchester, Connecticut with global manufacturing operations, Lydall delivers value-added engineered materials and specialty filtration solutions that promote a cleaner, quieter and safer world. We partner with our customers to develop bespoke, high-performing and efficient solutions that are adaptable and scalable to meet their needs. Lydall is a New York Stock Exchange-listed company. For more information, visit http://www.lydall.com. Lydall® is a registered trademark of Lydall, Inc. in the U.S. and other countries.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/37677714-d72f-4df2-92d3-39ce6e0a1e40

Media:
Danielle Orsino
Telephone 949-365-6609


Investors:
Brendan Moynihan
Telephone 860-646-1233
Facsimile 860-646-4917

www.lydall.com